ATE241609T1 - 7-carboxylatische flavon derivate, verfahren zur herstellung und verwendung als heilmittel - Google Patents

7-carboxylatische flavon derivate, verfahren zur herstellung und verwendung als heilmittel

Info

Publication number
ATE241609T1
ATE241609T1 AT01974441T AT01974441T ATE241609T1 AT E241609 T1 ATE241609 T1 AT E241609T1 AT 01974441 T AT01974441 T AT 01974441T AT 01974441 T AT01974441 T AT 01974441T AT E241609 T1 ATE241609 T1 AT E241609T1
Authority
AT
Austria
Prior art keywords
sub
group
carboxylatic
remedies
preparation
Prior art date
Application number
AT01974441T
Other languages
English (en)
Inventor
Jean-Pierre Gesson
Nadia Fonteneau
Martine Mondon
Suzy Charbit
Herve Ficheux
Francois Schutze
Original Assignee
Negma Lerads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negma Lerads filed Critical Negma Lerads
Application granted granted Critical
Publication of ATE241609T1 publication Critical patent/ATE241609T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT01974441T 2000-10-06 2001-10-05 7-carboxylatische flavon derivate, verfahren zur herstellung und verwendung als heilmittel ATE241609T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012846A FR2815033B1 (fr) 2000-10-06 2000-10-06 Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique
PCT/FR2001/003075 WO2002028851A1 (fr) 2000-10-06 2001-10-05 Dérivés de 7-carboxy-flavones, procédé de préparation et application en thérapeutique

Publications (1)

Publication Number Publication Date
ATE241609T1 true ATE241609T1 (de) 2003-06-15

Family

ID=8855113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01974441T ATE241609T1 (de) 2000-10-06 2001-10-05 7-carboxylatische flavon derivate, verfahren zur herstellung und verwendung als heilmittel

Country Status (15)

Country Link
US (1) US6965039B2 (de)
EP (1) EP1212313B1 (de)
JP (1) JP2004510770A (de)
CN (1) CN1301987C (de)
AT (1) ATE241609T1 (de)
AU (1) AU2001293956A1 (de)
BR (1) BR0114457A (de)
CA (1) CA2424993A1 (de)
DE (1) DE60100314T2 (de)
DK (1) DK1212313T3 (de)
ES (1) ES2199213T3 (de)
FR (1) FR2815033B1 (de)
MX (1) MXPA03002986A (de)
PT (1) PT1212313E (de)
WO (1) WO2002028851A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100841901B1 (ko) * 2002-03-18 2008-06-27 동화약품공업주식회사 플라보노이드 계열 화합물 또는 이를 포함하는 강진향추출물을 함유한 매트릭스 메탈로프로테이나제 활성저해제 및 기능성 식품
GB0412768D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
TW200924785A (en) * 2007-07-31 2009-06-16 Limerick Biopharma Inc Phosphorylated pyrone analogs and methods
CA2693340A1 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Pyrone analog compositions and methods
US20100297020A1 (en) * 2008-10-10 2010-11-25 Limerick Biopharma, Inc. Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
WO2010129138A2 (en) * 2009-04-27 2010-11-11 Limerick Biopharma Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
CN108329287B (zh) * 2018-02-24 2020-06-16 海南师范大学 大果榕中带有环氧基的化合物及其制备方法和应用
CN111388464A (zh) * 2020-04-28 2020-07-10 滨州医学院 芒柄花素磺酸钠在制备治疗类风湿性关节炎药物中的应用
CN111875571A (zh) * 2020-07-23 2020-11-03 长沙理工大学 一种从酱油渣中提取大豆异黄酮的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4157334A (en) 1974-12-26 1979-06-05 Carlo Erba S. P. A. 6-Carboxy-flavone derivatives and process for their preparation
FR2543140B1 (fr) 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
JPS62215581A (ja) 1986-03-18 1987-09-22 Koichi Shiyudo フラボンカルボン酸誘導体
DE3715779A1 (de) 1987-05-12 1988-11-24 Kali Chemie Pharma Gmbh Flavon-3-carbonsaeure-verbindungen sowie verfahren, zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2689127B1 (fr) 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5399584A (en) 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JP3957795B2 (ja) * 1996-10-04 2007-08-15 興和株式会社 フラボン誘導体及びこれを含有する医薬

Also Published As

Publication number Publication date
US6965039B2 (en) 2005-11-15
CN1468228A (zh) 2004-01-14
US20040059136A1 (en) 2004-03-25
PT1212313E (pt) 2003-10-31
FR2815033A1 (fr) 2002-04-12
CA2424993A1 (fr) 2002-04-11
EP1212313A1 (de) 2002-06-12
FR2815033B1 (fr) 2003-09-05
DK1212313T3 (da) 2003-09-22
JP2004510770A (ja) 2004-04-08
WO2002028851A1 (fr) 2002-04-11
BR0114457A (pt) 2003-10-21
AU2001293956A1 (en) 2002-04-15
DE60100314D1 (de) 2003-07-03
MXPA03002986A (es) 2004-05-24
CN1301987C (zh) 2007-02-28
ES2199213T3 (es) 2004-02-16
EP1212313B1 (de) 2003-05-28
DE60100314T2 (de) 2004-04-01

Similar Documents

Publication Publication Date Title
NO20023823D0 (no) Fremgangsmåte for tilvirkning og bruk av pyrrolopyrimidinon- derivater
NZ513561A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
ATE396988T1 (de) Chinolin- und chianzolinderivate zur behandlung von tumoren
EA200900934A1 (ru) НОВЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ NF-κB
ATE241609T1 (de) 7-carboxylatische flavon derivate, verfahren zur herstellung und verwendung als heilmittel
ATE235476T1 (de) Thiazolidindione derivate, ihre herstellung und verwendung
ID27178A (id) Senyawa aminosikloheksil eter dan penggunaannya
EA200700441A1 (ru) НОВЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ NF-κB
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
BR0313846A (pt) Derivados de dioxano-2-alquilcarbamatos, sua preparação e sua aplicação em terapêutica
ATE359786T1 (de) Camptothecin derivate
BR0105563A (pt) Derivados e análogos de galantamina
HUP0302115A2 (hu) Tiazabiciklo[3.2.2]nonán-fenil-izoxazol-származékok, előállításuk és ezeket tartalamzó gyógyszerkészítmények
EA200100059A2 (ru) Новые бензолсульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
BR9902692A (pt) Copolìmero de silano e um método para produção do mesmo
ATE273978T1 (de) 7-aminopyrido(2,3-d)-pyrimidine derivate zur behandlung von bronchialasthma
ATE269851T1 (de) Benzimidazole derivate
NO20033049D0 (no) Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1
ATE449063T1 (de) Verfahren zur herstellung von beta- hydroxyalkylamiden
ATE250597T1 (de) N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
BG103395A (en) Derivatives of benzenesulphonamide and medicaments containing them
BG104037A (en) 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
HUP0301561A2 (hu) Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
DE60007137D1 (de) Verfahren zur herstellung von 2-arylvinylalkylethern und 1,4-diaryl-2-fluor-2-butenen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1212313

Country of ref document: EP

REN Ceased due to non-payment of the annual fee